Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions.

Birtley JR, Alomary M, Zanini E, Antony J, Maben Z, Weaver GC, Von Arx C, Mura M, Marinho AT, Lu H, Morecroft EVN, Karali E, Chayen NE, Tate EW, Jurewicz M, Stern LJ, Recchi C, Gabra H.

Nat Commun. 2019 Jul 17;10(1):3134. doi: 10.1038/s41467-019-10966-8.

2.

MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Jurewicz MM, Willis RA, Ramachandiran V, Altman JD, Stern LJ.

Anal Biochem. 2019 Nov 1;584:113328. doi: 10.1016/j.ab.2019.05.017. Epub 2019 Jun 13.

PMID:
31201791
3.

HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Nanaware PP, Jurewicz MM, Leszyk JD, Shaffer SA, Stern LJ.

Mol Cell Proteomics. 2019 Mar;18(3):490-503. doi: 10.1074/mcp.RA118.000956. Epub 2018 Dec 20.

PMID:
30573663
4.

Class II MHC antigen processing in immune tolerance and inflammation.

Jurewicz MM, Stern LJ.

Immunogenetics. 2019 Mar;71(3):171-187. doi: 10.1007/s00251-018-1095-x. Epub 2018 Nov 12. Review.

PMID:
30421030
5.

Fertility Preservation in Pubertal and Pre-Pubertal Boys with Cancer.

Jurewicz M, Hillelsohn J, Mehta S, Gilbert BR.

Pediatr Endocrinol Rev. 2018 Mar;15(3):234-243. doi: 10.17458/per.vol15.2018.jhmg.fertilitypubertalboys.

PMID:
29493128
6.

Bulbocavernosus muscle area as a novel marker for hypogonadism.

Gupta N, Carvajal M, Jurewicz M, Gilbert BR.

Asian J Urol. 2017 Jan;4(1):3-9. doi: 10.1016/j.ajur.2016.11.002. Epub 2016 Nov 28.

7.

Imaging and angiography in male factor infertility.

Jurewicz M, Gilbert BR.

Fertil Steril. 2016 Jun;105(6):1432-42. doi: 10.1016/j.fertnstert.2016.04.009. Epub 2016 Apr 30. Review.

PMID:
27125229
8.

[The use of nanotechnology in medicinal products in the light of European Union law].

Jurewicz M.

Pol Merkur Lekarski. 2014 Dec;37(222):369-72. Review. Polish.

PMID:
25715580
9.

Approaching the optimal transurethral resection of a bladder tumor.

Jurewicz M, Soloway MS.

Turk J Urol. 2014 Jun;40(2):73-7. doi: 10.5152/tud.2014.94715. Review.

10.

The role of HCA2 (GPR109A) in regulating macrophage function.

Zandi-Nejad K, Takakura A, Jurewicz M, Chandraker AK, Offermanns S, Mount D, Abdi R.

FASEB J. 2013 Nov;27(11):4366-74. doi: 10.1096/fj.12-223933. Epub 2013 Jul 23.

11.

The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.

Azzi J, Moore RF, Elyaman W, Mounayar M, El Haddad N, Yang S, Jurewicz M, Takakura A, Petrelli A, Fiorina P, Ruckle T, Abdi R.

Diabetes. 2012 Jun;61(6):1509-18. doi: 10.2337/db11-0134. Epub 2012 Mar 8.

12.

Enuretic children with obstructive sleep apnea syndrome: should they see otolaryngology first?

Kovacevic L, Jurewicz M, Dabaja A, Thomas R, Diaz M, Madgy DN, Lakshmanan Y.

J Pediatr Urol. 2013 Apr;9(2):145-50. doi: 10.1016/j.jpurol.2011.12.013. Epub 2012 Jan 27.

PMID:
22285485
13.

Donor antioxidant strategy prolongs cardiac allograft survival by attenuating tissue dendritic cell immunogenicity(†).

Jurewicz M, Ueno T, Azzi J, Tanaka K, Murayama T, Yang S, Sayegh MH, Niimi M, Abdi R.

Am J Transplant. 2011 Feb;11(2):348-55. doi: 10.1111/j.1600-6143.2010.03360.x. Epub 2010 Dec 23.

14.

Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1.

Fiorina P, Jurewicz M, Vergani A, Petrelli A, Carvello M, D'Addio F, Godwin JG, Law K, Wu E, Tian Z, Thoma G, Kovarik J, La Rosa S, Capella C, Rodig S, Zerwes HG, Sayegh MH, Abdi R.

J Immunol. 2011 Jan 1;186(1):121-31. doi: 10.4049/jimmunol.1000799. Epub 2010 Dec 3.

15.

The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing.

Fiorina P, Pietramaggiori G, Scherer SS, Jurewicz M, Mathews JC, Vergani A, Thomas G, Orsenigo E, Staudacher C, La Rosa S, Capella C, Carothers A, Zerwes HG, Luzi L, Abdi R, Orgill DP.

Cell Transplant. 2010;19(11):1369-81. doi: 10.3727/096368910X514288. Epub 2010 Aug 17.

PMID:
20977829
16.

Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.

Jurewicz M, Yang S, Augello A, Godwin JG, Moore RF, Azzi J, Fiorina P, Atkinson M, Sayegh MH, Abdi R.

Diabetes. 2010 Dec;59(12):3139-47. doi: 10.2337/db10-0542. Epub 2010 Sep 14.

17.

A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.

Vergani A, D'Addio F, Jurewicz M, Petrelli A, Watanabe T, Liu K, Law K, Schuetz C, Carvello M, Orsenigo E, Deng S, Rodig SJ, Ansari JM, Staudacher C, Abdi R, Williams J, Markmann J, Atkinson M, Sayegh MH, Fiorina P.

Diabetes. 2010 Sep;59(9):2253-64. doi: 10.2337/db09-1264.

18.

Polylactide-cyclosporin A nanoparticles for targeted immunosuppression.

Azzi J, Tang L, Moore R, Tong R, El Haddad N, Akiyoshi T, Mfarrej B, Yang S, Jurewicz M, Ichimura T, Lindeman N, Cheng J, Abdi R.

FASEB J. 2010 Oct;24(10):3927-38. doi: 10.1096/fj.10-154690. Epub 2010 Jun 14.

19.

Ischemic injury enhances dendritic cell immunogenicity via TLR4 and NF-kappa B activation.

Jurewicz M, Takakura A, Augello A, Movahedi Naini S, Ichimura T, Zandi-Nejad K, Abdi R.

J Immunol. 2010 Mar 15;184(6):2939-48. doi: 10.4049/jimmunol.0901889. Epub 2010 Feb 17.

20.

Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.

Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, Selig M, Godwin J, Law K, Placidi C, Smith RN, Capella C, Rodig S, Adra CN, Atkinson M, Sayegh MH, Abdi R.

J Immunol. 2009 Jul 15;183(2):993-1004. doi: 10.4049/jimmunol.0900803. Epub 2009 Jun 26.

21.

The renin-angiotensin system: an old, newly discovered player in immunoregulation.

Geara AS, Azzi J, Jurewicz M, Abdi R.

Transplant Rev (Orlando). 2009 Jul;23(3):151-8. doi: 10.1016/j.trre.2009.04.002. Review.

PMID:
19539879
22.

Divergent role of donor dendritic cells in rejection versus tolerance of allografts.

Ueno T, Tanaka K, Jurewicz M, Murayama T, Guleria I, Fiorina P, Paez JC, Augello A, Vergani A, Wong M, Smith RN, Abdi R.

J Am Soc Nephrol. 2009 Mar;20(3):535-44. doi: 10.1681/ASN.2008040377. Epub 2009 Jan 7.

23.

Targeting CD22 reprograms B-cells and reverses autoimmune diabetes.

Fiorina P, Vergani A, Dada S, Jurewicz M, Wong M, Law K, Wu E, Tian Z, Abdi R, Guleria I, Rodig S, Dunussi-Joannopoulos K, Bluestone J, Sayegh MH.

Diabetes. 2008 Nov;57(11):3013-24. doi: 10.2337/db08-0420. Epub 2008 Aug 8.

24.

Phenotypic and functional differences between wild-type and CCR2-/- dendritic cells: implications for islet transplantation.

Fiorina P, Jurewicz M, Vergani A, Augello A, Paez J, Ricchiuti V, Tchipachvili V, Sayegh MH, Abdi R.

Transplantation. 2008 Apr 15;85(7):1030-8. doi: 10.1097/TP.0b013e31816843a0.

PMID:
18408585
25.

Importance of donor- and recipient-derived selectins in cardiac allograft rejection.

Izawa A, Ueno T, Jurewicz M, Ito T, Tanaka K, Takahashi M, Ikeda U, Sobolev O, Fiorina P, Smith RN, Hynes RO, Abdi R.

J Am Soc Nephrol. 2007 Nov;18(11):2929-36. Epub 2007 Oct 10.

26.

Role of beta3 integrin in acute renal allograft rejection in humans.

Chandrakantan A, McDermott DH, Tran HT, Jurewicz M, Gallon L, Gaston R, Milford E, Abdi R.

Clin J Am Soc Nephrol. 2007 Nov;2(6):1268-73. Epub 2007 Oct 10.

27.

A link between PDL1 and T regulatory cells in fetomaternal tolerance.

Habicht A, Dada S, Jurewicz M, Fife BT, Yagita H, Azuma M, Sayegh MH, Guleria I.

J Immunol. 2007 Oct 15;179(8):5211-9.

28.

A novel alloantigen-specific CD8+PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo.

Izawa A, Yamaura K, Albin MJ, Jurewicz M, Tanaka K, Clarkson MR, Ueno T, Habicht A, Freeman GJ, Yagita H, Abdi R, Pearson T, Greiner DL, Sayegh MH, Najafian N.

J Immunol. 2007 Jul 15;179(2):786-96.

29.

Beta 3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection.

Lacy-Hulbert A, Ueno T, Ito T, Jurewicz M, Izawa A, Smith RN, Chase CM, Tanaka K, Fiorina P, Russell PS, Auchincloss H Jr, Sayegh MH, Hynes RO, Abdi R.

Am J Transplant. 2007 May;7(5):1080-90. Epub 2007 Mar 12.

30.

Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation.

Jurewicz M, McDermott DH, Sechler JM, Tinckam K, Takakura A, Carpenter CB, Milford E, Abdi R.

J Am Soc Nephrol. 2007 Apr;18(4):1093-102. Epub 2007 Feb 28.

31.

Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival.

Fiorina P, Jurewicz M, Tanaka K, Behazin N, Augello A, Vergani A, von Andrian UH, Smith NR, Sayegh MH, Abdi R.

Diabetes. 2007 Apr;56(4):912-20. Epub 2007 Feb 7. Erratum in: Diabetes. 2007 Jun;56(6):1747. Von Adrian, Uli [corrected to von Andrian, Ulrich H].

32.

Role of CXC chemokine receptor 3 pathway in renal ischemic injury.

Fiorina P, Ansari MJ, Jurewicz M, Barry M, Ricchiuti V, Smith RN, Shea S, Means TK, Auchincloss H Jr, Luster AD, Sayegh MH, Abdi R.

J Am Soc Nephrol. 2006 Mar;17(3):716-23. Epub 2006 Feb 15.

33.

Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection.

Habicht A, Clarkson MR, Yang J, Henderson J, Brinkmann V, Fernandes S, Jurewicz M, Yuan X, Sayegh MH.

J Immunol. 2006 Jan 1;176(1):36-42.

34.

Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.

Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H Jr, Sayegh MH, Najafian N.

J Immunol. 2005 Jun 1;174(11):6648-56.

35.

Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.

Abdi R, Means TK, Ito T, Smith RN, Najafian N, Jurewicz M, Tchipachvili V, Charo I, Auchincloss H Jr, Sayegh MH, Luster AD.

J Immunol. 2004 Jan 15;172(2):767-75.

36.

Anaphylaxis. When the body overreacts.

Jurewicz MA.

Nursing. 2000 Jul;30(7):58-61. No abstract available.

PMID:
10983103
37.

Neutral sugar composition of the seromucoid and non-diffusible blood sugar-peptide fractions in streptozotocin diabetic rats.

Turyna B, Sarnecka-Keller M, Jurewicz M.

Horm Metab Res. 1981 Oct;13(10):550-2. No abstract available.

PMID:
7298010
38.

[A device for the repair and fixation of fractures of the zygomatic bone and arch].

Jedraszko B, Jurewicz M.

Czas Stomatol. 1967 Aug;20(8):843-7. Polish. No abstract available.

PMID:
5233701
39.

[An unusual case of ossifying fibroma].

Jurewicz M, Pruszczyński M.

Czas Stomatol. 1965 Jul;18(7):795-8. Polish. No abstract available.

PMID:
5221268

Supplemental Content

Loading ...
Support Center